Drug Profile
Terbinafine lacquer
Alternative Names: InnoNyx; MycoVa; NM02101; NM100060Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator NexMed
- Developer Apricus Biosciences; Novartis
- Class Amines; Antifungals; Naphthalenes; Skin disorder therapies; Small molecules
- Mechanism of Action Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Onychomycosis